USPTO serial 79324999
ANAXIS PHARMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 4, 2023
- Examiner
- KEAN, AMY C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ANAXIS PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Neil B Friedman
Neil B Friedman Hodgson Russ LLP605 Third Avenue, Suite 2300New York, NY 10158UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific research and development; Pharmaceutical research and development; Pharmaceutical research advisory and pharmaceutical testing services; Preparation of scientific reports; Scientific research, design, analysis and testing of pharmaceutical products; Conducting medical research; Conducting clinical trials for others in the field of pharmaceuticals; Provision of scientific information in the field of pharmaceutical products; Scientific and technical analysis in the field of medical and scientific research and pharmaceutical product research; Scientific research consultancy in the field of pharmaceuticals; Scientific research in the field of pharmacy; Medical research; research and development of products; Research relating to pharmaceuticals; Advisory and consultancy services relating to the aforementioned services | ACTIVE | — |
| 045 | Licensing of intellectual property rights; Legal services relating to the exploitation of patent and copyright intellectual property rights; Enforcement of intellectual property rights; Advisory services relating to intellectual property rights; Research relating to intellectual property | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Anaxis Pharma Pty Ltd
- Other trademarks owned by Anaxis Pharma Pty Ltd
- Other trademarks owned by Anaxis Pharma Pty Ltd
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named ANAXIS PHARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 30, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 14, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 21, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 21, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 4, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 4, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 4, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 24, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 17, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 17, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 4, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 4, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 28, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 15, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 2, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 2, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 2, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 14, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 19, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 30, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 30, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 16, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 15, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 15, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 12, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 8, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 4, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |